It is approved for type 2 diabetes, but is used off-label for weight loss in overweight or obese patients under medical supervision
Dual, enzymatic and non-enzymatic, function of ecto-5-nucleotidase (eN, CD73) in migration and invasion of A375 melanoma cells
Similarly, when Zepbound was approved in November 2023, tirzepatide prescriptions jumped from 1.1 million to 1.4 million by February 2024
June 2024: Mounjaro manufacturer issued an Open Letter warning patients against using the drug for cosmetic weight loss and counterfeit versions of the drug
Non-alcoholic fatty liver disease (NAFLD) , now increasingly referred to as metabolic dysfunction-associated steatotic liver disease (MASLD) , affects approximately one in three adults in the UK
Note when you feel most tempted to eat, when nausea would be least disruptive, and when you're most active